Gossamer Bio (GOSS) Earnings Date, Estimates & Call Transcripts $1.32 -0.01 (-0.38%) As of 12:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Gossamer Bio Earnings Summary Gossamer Bio posted Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.16, which topped analysts' consensus estimates of -$0.18 by $0.02. Quarterly revenue was reported to be $9.89 million, above analyst estimates of $3.95 million. With a trailing EPS of -$0.23, Gossamer Bio's earnings are expected to decrease next year, from ($0.28) to ($0.70) per share. Upcoming Q2 Earnings DateAug. 11Before Market OpensEstimatedConsensus EPS (May. 15) -$0.18 Actual EPS (May. 15) -$0.16 Beat By $0.02 Actual Revenue (May. 15) $9.89MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)GOSS Upcoming EarningsGossamer Bio's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Gossamer Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gossamer Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGOSS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GOSS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Gossamer Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.22-$0.16-$0.18Q2 20253-$0.23-$0.15-$0.18Q3 20253-$0.24-$0.16-$0.19Q4 20253-$0.25-$0.03-$0.15 FY 2025 12 -$0.94 -$0.50 -$0.71 Q1 20261-$0.09-$0.09-$0.09Q2 20261-$0.07-$0.07-$0.07Q3 20261-$0.04-$0.04-$0.04Q4 20261$0.03$0.03$0.03 Gossamer Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------5/15/2025Q1 2025-$0.18-$0.16+$0.02-$0.16$3.95M$9.89M3/18/2025Q4 2024-$0.15-$0.15--$0.15$7.02M$9.38M11/7/2024--$0.18-$0.14+$0.04-$0.14$4.52M$9.48M8/12/2024Q2 2024$0.23$0.22 -$0.01$0.22$160.00M$95.84M5/7/2024Q1 2024-$0.19-$0.19--$0.19--3/5/2024Q4 2023-$0.21-$0.21--$0.21--11/9/2023Q3 2023-$0.20-$0.21 -$0.01-$0.21--8/8/2023Q2 2023-$0.49-$0.45+$0.04-$0.45-- Gossamer Bio Earnings - Frequently Asked Questions When is Gossamer Bio's earnings date? Gossamer Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on GOSS's earnings history. Did Gossamer Bio beat their earnings estimates last quarter? In the previous quarter, Gossamer Bio (NASDAQ:GOSS) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.18) by $0.02. Learn more on analysts' earnings estimate vs. GOSS's actual earnings. How can I listen to Gossamer Bio's earnings conference call? The conference call for Gossamer Bio's latest earnings report can be listened to online. Listen to Conference Call How can I read Gossamer Bio's conference call transcript? The conference call transcript for Gossamer Bio's latest earnings report can be read online. Read Transcript How much revenue does Gossamer Bio generate each year? Gossamer Bio (NASDAQ:GOSS) has a recorded annual revenue of $124.59 million. How much profit does Gossamer Bio generate each year? Gossamer Bio (NASDAQ:GOSS) has a recorded net income of -$179.82 million. GOSS has generated -$0.23 earnings per share over the last four quarters. What is Gossamer Bio's EPS forecast for next year? Gossamer Bio's earnings are expected to decrease from ($0.28) per share to ($0.70) per share in the next year. More Earnings Resources from MarketBeat Related Companies CureVac Earnings Mineralys Therapeutics Earnings Phibro Animal Health Earnings Arcus Biosciences Earnings Wave Life Sciences Earnings Syndax Pharmaceuticals Earnings Collegium Pharmaceutical Earnings Enliven Therapeutics Earnings Spyre Therapeutics Earnings Nurix Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:GOSS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s Secret WeaponThe Trump-Elon War Could Trigger an Economic Collapse - Here's Your Only Safe Exit This isn't just a war of...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored50-year legend: Here’s exact day stocks will crashGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gossamer Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gossamer Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GOSS Stock Free GOSS Stock Alerts